FDA SARS-CoV-2 Reference Panel Comparative Data The FDA SARS-CoV-2 Reference Panel Comparative Data spreadsheet compiles EUA-reported LoDs and FDA reference panel LoDs for many authorized molecular tests, enabling side-by-side comparison of relative analytical sensitivity across developers and platforms. It includes test names, developers, notes on data-release wave and versioning caveats, and a calculated FDA/EUA LoD ratio to highlight discrepancies between EUA-submitted LoD claims and reference-panel results. primary file regulatory fda-policy FDA SARS-CoV-2 Reference Panel Comparative Data - Complied by Matt McFarlane.md regulatory/fda-policy/FDA SARS-CoV-2 Reference Panel Comparative Data - Complied by Matt McFarlane.md 2021_01_11 Missing date, unsure about license xlsx xlsx 3rd Party 3124 6657 gfile-url xfile-github-download-url pdf-gdrive-url pdf-github-url github-markdown-url github-markdown-download-url web-pdf-url web-slides-url youtube-url web-url